Millipore Sigma Vibrant Logo

567809 Src Inhibitor, PP1 - CAS 172889-26-8 - Calbiochem

The Src Inhibitor PP1, also referenced under CAS 172889-26-8, controls the biological activity of Src. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine

View Products on Sigmaaldrich.com
567809
查看价格及供货情况

概述

Replacement Information

重要规格表

CAS #Empirical Formula
172889-26-8C₁₆H₁₉N₅

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
567809-1MGCN
正在查询供货情况......
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      		 玻璃瓶 1 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell-permeable pyrazolopyrimidine compound that is shown to inhibit Src family tyrosine kinases Lck, Fyn, Hck, and Src (IC50 = 5, 6, 20, and 170 nM, respectively), as well as non-Src family kinases such as CSK, RIP2, and CK1δ (IC50 = 640 nM, 26 nM, 170 nM, respectively), in in vitro kinase assays. At 1 µM, in vitro kinase activity is reduced by more than 57% for p38α, p38β, CK1δ, CSK, RIP2, and GAK, while exhibiting much lower activity against more than 60 other kinases. Kinetic studies employing Src and [poly Glu-Tyr 4:1] indicate that the inhibition is mixed competitive with respect to the substrate and non-competitive with respect to ATP. PP1 also demonstrates anti-growth properties in several B lymphoma cultures of human and murine origins (IC50 = 2.5 to 8.0 µM) and pediatric brain tumor cells (IC50 = 1.1 to 9.7 µM). Also available in InSolution™ format (Cat. No. 539741).
      Catalogue Number567809
      Brand Family Calbiochem®
      Synonyms4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine
      References
      ReferencesKe, J., et.al. 2009. Mol. Cancer 8, 132.
      Sikkema, A.H., et al. 2009. Cancer Res. 69, 5987.
      Bain, J., et al. 2007. Biochem. J. 408, 297.
      Bain, J., et al. 2003. Biochem. J. 371, 199.
      Karni, R., et al. 2003. FEBS Lett. 537, 47.
      Hanke, J.H., et al. 1996. J. Biol. Chem. 271, 695.
      Product Information
      CAS number172889-26-8
      FormOff-white solid
      Hill FormulaC₁₆H₁₉N₅
      Chemical formulaC₁₆H₁₉N₅
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      567809-1MGCN 04055977190373

      Documentation

      Src Inhibitor, PP1 - CAS 172889-26-8 - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      Src Inhibitor, PP1 - CAS 172889-26-8 - Calbiochem 分析证书

      标题批号
      567809

      参考

      参考信息概述
      Ke, J., et.al. 2009. Mol. Cancer 8, 132.
      Sikkema, A.H., et al. 2009. Cancer Res. 69, 5987.
      Bain, J., et al. 2007. Biochem. J. 408, 297.
      Bain, J., et al. 2003. Biochem. J. 371, 199.
      Karni, R., et al. 2003. FEBS Lett. 537, 47.
      Hanke, J.H., et al. 1996. J. Biol. Chem. 271, 695.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision28-April-2015 JSW
      Synonyms4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-d-3,4-pyrimidine
      DescriptionA cell-permeable pyrazolopyrimidine compound that is shown to inhibit Src family tyrosine kinases Lck, Fyn, Hck, and Src (IC50 = 5, 6, 20, and 170 nM, respectively), as well as non-Src family kinases such as CSK, RIP2, and CK1δ (IC50 = 640 nM, 26 nM, 170 nM, respectively), in in vitro kinase assays. At 1 µM, in vitro kinase activity is reduced by more than 57% for p38α, p38β, CK1δ, CSK, RIP2, and GAK, while exhibiting much lower activity against more than 60 other kinases. Kinetic studies employing Src and [poly Glu-Tyr 4:1] indicate that the inhibition is mixed competitive with respect to the substrate and non-competitive with respect to ATP. PP1 also demonstrates anti-growth properties in several B lymphoma cultures of human and murine origins (IC50 = 2.5 to 8.0 µM) and pediatric brain tumor cells (IC50 = 1.1 to 9.7 µM). Also available in InSolution™ format (Cat. No. 539741.
      FormOff-white solid
      CAS number172889-26-8
      Chemical formulaC₁₆H₁₉N₅
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (25 mg/ml)
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesKe, J., et.al. 2009. Mol. Cancer 8, 132.
      Sikkema, A.H., et al. 2009. Cancer Res. 69, 5987.
      Bain, J., et al. 2007. Biochem. J. 408, 297.
      Bain, J., et al. 2003. Biochem. J. 371, 199.
      Karni, R., et al. 2003. FEBS Lett. 537, 47.
      Hanke, J.H., et al. 1996. J. Biol. Chem. 271, 695.